Direct-to-consumer Marketing to People with Hemophilia

Philip Kucab; Katelyn Dow Stepanyan; Adriane Fugh-Berman

doi:10.1371/journal.pmed.1001996

Direct-to-consumer Marketing to People with Hemophilia

PLoS Med. 2016 Jun 14;13(6):e1001996. doi: 10.1371/journal.pmed.1001996. eCollection 2016 Jun.

Authors

Philip Kucab¹, Katelyn Dow Stepanyan², Adriane Fugh-Berman³

Affiliations

¹ Department of Neurology, Detroit Medical Center, Detroit, Michigan, United States of America.
² Department of Internal Medicine, University of California, Los Angeles, Los Angeles, California, United States of America.
³ Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, District of Columbia, United States of America.

Abstract

Adriane Fugh-Berman and colleagues describe how strategies similar to those used to market drugs to physicians are directed towards people with hemophilia.

MeSH terms

Direct-to-Consumer Advertising / economics*
Hemophilia A / drug therapy*
Humans
Patients / psychology*

Grants and funding

No funding was received for this work.